Login / Signup

Understanding p300-transcription factor interactions using sequence variation and hybridization.

Fruzsina HóborZsofia HegedüsAmaurys Avila IbarraVencel L PetroviczGail J BartlettRichard B SessionsAndrew J WilsonThomas A Edwards
Published in: RSC chemical biology (2022)
The hypoxic response is central to cell function and plays a significant role in the growth and survival of solid tumours. HIF-1 regulates the hypoxic response by activating over 100 genes responsible for adaptation to hypoxia, making it a potential target for anticancer drug discovery. Although there is significant structural and mechanistic understanding of the interaction between HIF-1α and p300 alongside negative regulators of HIF-1α such as CITED2, there remains a need to further understand the sequence determinants of binding. In this work we use a combination of protein expression, chemical synthesis, fluorescence anisotropy and isothermal titration calorimetry for HIF-1α sequence variants and a HIF-1α-CITED hybrid sequence which we term CITIF. We show the HIF-1α sequence is highly tolerant to sequence variation through reduced enthalpic and less unfavourable entropic contributions, These data imply backbone as opposed to side chain interactions and ligand folding control the binding interaction and that sequence variations are tolerated as a result of adopting a more disordered bound interaction or "fuzzy" complex.
Keyphrases
  • endothelial cells
  • transcription factor
  • drug discovery
  • amino acid
  • gene expression
  • genome wide
  • preterm infants
  • risk assessment
  • climate change
  • human health
  • quantum dots
  • binding protein
  • big data
  • nucleic acid